The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b.
Activated protein C (APC), the only FDA-approved biotherapeutic drug for sepsis, possesses anticoagulant, antiinflammatory, and barrier-protective activities. However, the mechanisms underlying its anti-inflammatory functions are not well defined. Here, we report that the antiinflammatory activity of APC on macrophages is dependent on integrin CD11b/CD18, but not on endothelial protein C receptor (EPCR). We showed that CD11b/CD18 bound APC within specialized membrane microdomains/lipid rafts and facilitated APC cleavage and activation of protease-activated receptor-1 (PAR1), leading to enhanced production of sphingosine-1-phosphate (S1P) and suppression of the proinflammatory response of activated macrophages. Deletion of the gamma-carboxyglutamic acid domain of APC, a region critical for its anticoagulant activity and EPCR-dependent barrier protection, had no effect on its antiinflammatory function. Genetic inactivation of CD11b, PAR1, or sphingosine kinase-1, but not EPCR, abolished the ability of APC to suppress the macrophage inflammatory response in vitro. Using an LPS-induced mouse model of lethal endotoxemia, we showed that APC administration reduced the mortality of wild-type mice, but not CD11b-deficient mice. These data establish what we believe to be a novel mechanism underlying the antiinflammatory activity of APC in the setting of endotoxemia and provide clear evidence that the antiinflammatory function of APC is distinct from its barrier-protective function and anticoagulant activities.
Cao
Chunzhang
C
Center for Vascular and Inflammatory Diseases, Department of Physiology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
Gao
Yamei
Y
Li
Yang
Y
Antalis
Toni M
TM
Castellino
Francis J
FJ
Zhang
Li
L
D015055:1-Carboxyglutamic Acid / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D019446:Endotoxemia / Q000378:metabolism*; D016023:Integrins / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000378:metabolism / Q000494:pharmacology; D008246:Lysophospholipids; D021962:Membrane Microdomains / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D017853:Phosphotransferases (Alcohol Group Acceptor); D011486:Protein C / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D018805:Sepsis / Q000378:metabolism*; D013110:Sphingosine / Q000031:analogs & derivatives; D000099157:Sphingosine Kinase
D015055:1-Carboxyglutamic Acid; D016023:Integrins; D008070:Lipopolysaccharides; D008246:Lysophospholipids; D017853:Phosphotransferases (Alcohol Group Acceptor); D011486:Protein C; D013110:Sphingosine; D000099157:Sphingosine Kinase; C060506:sphingosine 1-phosphate
J Immunol. 2000 Oct 15;165(8):4697-703
11035113
Blood. 2005 Oct 15;106(8):2716-22
15956290
J Thromb Haemost. 2009 Jul;7 Suppl 1:127-31
19630784
J Clin Invest. 2009 Jul;119(7):1871-9
19603543
Crit Care Med. 2009 Jan;37(1 Suppl):S30-7
19104223
Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2634-41
17932312
Science. 2002 Jun 7;296(5574):1880-2
12052963
J Immunol. 2008 Aug 1;181(3):2165-73
18641355
J Biol Chem. 2004 Dec 10;279(50):52487-92
15459201
Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):274-9
19116273
Cell Res. 1999 Sep;9(3):171-8
10520599
Blood. 2003 Aug 15;102(4):1499-505
12714492
Blood. 2008 Mar 1;111(5):2667-73
18089851
J Immunol. 2006 Jan 15;176(2):1019-25
16393989
J Thromb Haemost. 2008 Jun;6(6):954-61
18284602
Nat Rev Drug Discov. 2005 Oct;4(10):854-65
16224456
Circ Res. 2008 Nov 7;103(10):1164-72
18849324
Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):504-10
18174455
Circulation. 1990 Aug;82(2):578-85
2372904
J Immunol. 1998 Dec 15;161(12):6463-7
9862668
J Clin Invest. 2009 Nov;119(11):3437-49
19841542
Blood. 2009 Apr 23;113(17):4078-85
19244161
J Immunol. 2003 Jul 15;171(2):1042-50
12847278
J Biol Chem. 1983 May 10;258(9):5548-53
6304092
Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4423-8
12671072
N Engl J Med. 2001 Mar 8;344(10):699-709
11236773
J Biol Chem. 1994 Oct 21;269(42):26486-91
7929370
EMBO J. 1995 Feb 1;14(3):422-31
7532130
Blood. 2005 Nov 1;106(9):3234-41
16002427
J Thromb Haemost. 2007 Jul;5(7):1394-400
17445091
Blood. 2007 Apr 15;109(8):3161-72
17110453
Science. 1999 Oct 8;286(5438):291-5
10514372
Immunity. 1996 Dec;5(6):653-66
8986723
Circ Res. 2008 Apr 25;102(8):950-8
18323526
J Leukoc Biol. 2005 Feb;77(2):129-40
15548573
J Immunol. 2006 Aug 15;177(4):2115-22
16887970
J Biol Chem. 1996 Jul 26;271(30):18211-6
8663418
J Biol Chem. 2003 Sep 5;278(36):34395-402
12816955
J Immunol. 1994 Oct 15;153(8):3664-72
7523500
J Exp Med. 2007 Oct 1;204(10):2439-48
17893198
Blood. 2009 Jun 4;113(23):5970-8
19244160
EMBO J. 2006 May 3;25(9):1860-70
16601674
J Biol Chem. 1982 Jul 25;257(14):7944-7
6282863
Nat Med. 2003 Mar;9(3):338-42
12563316
Blood. 2006 Feb 15;107(4):1454-8
16223773